Nanovi Secures €2.7M to Market BioXmark™ and Expands Board of Directors
Copenhagen, Denmark, September 29, 2014 / B3C newswire / - Nanovi, specialized in the development of advanced biomaterials for use in the radiotherapy of cancer, today announced it secured €2.7M from current investors to bring BioXmark™ technology to the …